A Meeting of the FCCB Committee of the Company is scheduled on Wednesday, 19-August-2026 to consider and approve conversion a portion of funds raised through FCCBs into equity shares and allotment thereof.
FCCB Committee Meeting On Wednesday, 19-August-2026
Filed with BSE · · 1 page · English
Summary by 6ix AI
Sudarshan Pharma Industries Ltd has announced a meeting of its FCCB Committee scheduled for a specific date to discuss financial matters related to funds raised through an FCCB issue. The meeting will focus on the conversion of a portion of these funds into equity shares and their subsequent allotment. This filing serves to inform the stock exchange and shareholders about the upcoming meeting and its agenda.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Sudarshan Pharma Industries Ltd on 6ix
Earlier from Sudarshan Pharma Industries
- Announcement under Regulation 30 (LODR)-Investor Presentation
- Sudarshan Pharma Industries Ltd Press Release Aug 10 2026
- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
- Sudarshan Pharma Industries Ltd Press Release Aug 09 2026
- Board Meeting Intimation for To Consider And Approve Financial Results For The Quarter Ended 30/June/2026
Later from Sudarshan Pharma Industries
- Sudarshan Pharma Industries Ltd Press Release Aug 17 2026
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Sudarshan Pharma Industries Ltd Press Release Aug 18 2026
- Sudarshan Pharma Industries Ltd Press Release Aug 22 2026
- Annual General Meeting Of The Company On Tuesday, 22/September/2026
Follow Sudarshan Pharma Industries into a list and get an email when it puts out news.
Follow Sudarshan Pharma Industries